Tuesday, November 10, 2020, 5:00 PM - Tuesday, November 17, 2020, 7:00 PM


The 17th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course will provide an in-depth review of strategies for participants to better diagnosis, classify and achieve remission in patients with Inflammatory Bowel Diseases. State-of-the-art lectures will be given by expert faculty on optimizing therapies, innovative treatment, and epidemiology of IBD. This internet live webinar will confront challenging clinical scenarios such as IBD Mimickers, GI Bleeds, and Extraintestinal Manifestations of IBD. The goal is to meet the need of our IBD patients by addressing sub-optimal disease control, preventable disease complications, and potential negative consequences of therapy.

1. • Discuss the most common infectious and non-infectious IBD mimickers
2. • Discuss the epidemiology and risk factors of Inflammatory Bowel Disease
3. • Review the options for treatment of GI bleeds
4. • Discuss effective management of extraintestinal manifestations of IBD

Live Q&A Webinar: Nov 10, Nov 17

 Physicians $300

 Nurse/Allied Health Professionals $175

 Fellows, Residents $50

*If registering for this course along with the GIHep course, please see the rates below: 

 Physicians $500

 Nurse/Allied Health Professionals $200

 Fellows, Residents $75 

Cancellation Policy
All refund and cancellation requests must be emailed to the CME office at cme@mssm.edu by November 6, 2020. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal to or less than $50.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (4.00 hours), AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours), Non-Physician Attendance (4.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.